Will the ‘dream of immortality’ come true thanks to the artificial heart?

With the advent of the artificial heart, many people have had a new life that once existed only in thought or through “miracles”.

Recently, the artificial hearts of Syncardia and Carmat were approved for commercial use. This means that more and more artificial hearts will soon appear around the world. This artificial heart is made of a biological material with a structure similar to the human heart, consisting of two ventricles, two atriums and four valves, and sensors, lithium batteries, and some another ingredient inside.

The structure of an artificial heart is similar to that of a human heart.

The external unit can be fixed on the body for charging, to ensure the lithium battery in the heart has power at all times. They hold enough energy to help the artificial heart automatically adjust the rate of blood flow throughout the body, according to changes in human activity and movement. The main function of an artificial heart is that, in the face of a depletion, it can replace and recognize life-changing mechanisms.

The data shows that now 81 patients have had an artificial heart transplant worldwide. As technology advances in the future, artificial hearts with a longer lifespan will be perfected and humans will almost become “immortal”.

Oil king John Davison Rockefeller previously spent $ 300 million to replace six hearts in 38 years (by the donor) and lived to 101 as he wanted (some documents show that Rockefeller died when he was about to turn age 98). Now the advent of the artificial heart could provide a new option to prolong life without worrying about the heart’s origin or fitness.

After brain-computer interfaces, gene editing and nano-robots, the advent of the artificial heart has added a new magical weapon to the realm of life-prolonging technology. Since the beginning of the 21st century, the development of life-prolonging intervention technology has made great progress. Regarding human longevity in the future, Sinclair, a professor of genetics at Harvard Medical School, said that we are witnessing new developments in technology and that one day all humans can live. to 150 years old.

Modern science and technology is different, after many years of development, it is easy to achieve a certain extent to prolonging life and slowing down the aging process. Not only the artificial heart, the famous academic journal Nature recently selected the “Seven Major Aging Intervention Technologies,” including a β-nicotinamide derivative from Harvard lab, included in the experiment.

Sinclair, who discovered how the substance works, revealed that there is an important coenzyme called NAD +, which is equivalent to the body’s energy production plant, but its content is not static and will decrease with age. This is the cause of problems like aging and depression.

Scientists selected white mice with a genetic similarity to humans and discovered that, by giving β-nicotinamide derivative to supplement their enzyme levels, lifespan was left. rat’s were lasted from 2 months to 4.5 months. However, the cost for this material is very high.

Although the derivative was subsequently mass produced and cost-reduced through enzyme-oriented technology, the beneficiaries were still predominantly high-income groups. Although this biotechnology achievement makes many people eager to try it, it is not accessible to everyone.

To close the financial resource gap and longevity between rich and poor, the price barrier of β-nicotinamide is a major hurdle to address. Meanwhile, the famous investment bank Bank of America Merrill Lynch predicted that the global anti-aging industry has a huge potential market of up to $ 600 billion.

After the 19th century, the average human life expectancy in the world has increased at a rate of about 1-3 years every 5 years, now the average life expectancy in some countries has reached 77 years. Public health is an important factor, and technology can become another “springboard” to increase the average human lifespan.

For example, Elon Musk’s computer-brain interface is about to go further on an experimental basis. In the future, it may be possible to realize so-called “artificial intelligence immortality”, or some other type of-nicotinamide-like metabolic derivative. Amide derivatives slow down the body’s aging process from the cellular level, so the average human life span will be further improved.

Well-known analysts Kes Tran and Haim Israel have released a research report showing that companies committed to “delaying human death” should first have the opportunity to consider investing. Healthy longevity reduces the burden on the elderly in society and provides the middle-aged and the elderly with a higher quality of life in the later years of life.

Phong Vu

The fight against food waste with high technology

The fight against food waste with high technology

Japanese companies are increasing the use of artificial intelligence and other modern technologies to reduce waste and reduce costs in Covid-19 translation.


Leave a Reply

Your email address will not be published. Required fields are marked *